Annual EBITDA
-$32.48 M
+$50.20 M+60.72%
31 December 2023
Summary:
Finch Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$32.48 million, with the most recent change of +$50.20 million (+60.72%) on 31 December 2023. During the last 3 years, it has risen by +$6.16 million (+15.95%). FNCH annual EBITDA is now -57.22% below its all-time high of -$20.66 million, reached on 31 December 2019.FNCH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$6.07 M
-$944.00 K-18.43%
30 June 2024
Summary:
Finch Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$6.07 million, with the most recent change of -$944.00 thousand (-18.43%) on 30 June 2024. Over the past year, it has dropped by -$2.38 million (-64.68%). FNCH quarterly EBITDA is now -64.68% below its all-time high of -$3.68 million, reached on 30 September 2023.FNCH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$19.51 M
+$2.96 M+13.17%
30 June 2024
Summary:
Finch Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$19.51 million, with the most recent change of +$2.96 million (+13.17%) on 30 June 2024. Over the past year, it has increased by +$27.51 million (+58.52%). FNCH TTM EBITDA is now -153.26% below its all-time high of -$7.70 million, reached on 31 March 2020.FNCH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FNCH EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.7% | -64.7% | +58.5% |
| 3 y3 years | +15.9% | +34.8% | +62.6% |
| 5 y5 years | - | - | - |
FNCH EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +60.7% | -64.7% | +73.9% | at high | +76.4% |
| 5 y | 5 years | -57.2% | +60.7% | -64.7% | +73.9% | -153.3% | +76.4% |
| alltime | all time | -57.2% | +60.7% | -64.7% | +73.9% | -153.3% | +76.4% |
Finch Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$6.07 M(+18.4%) | -$19.51 M(-13.2%) |
| Mar 2024 | - | -$5.12 M(+10.4%) | -$22.46 M(-30.8%) |
| Dec 2023 | -$32.48 M(-60.7%) | -$4.64 M(+25.9%) | -$32.48 M(-30.9%) |
| Sept 2023 | - | -$3.68 M(-59.2%) | -$47.02 M(-25.6%) |
| June 2023 | - | -$9.02 M(-40.4%) | -$63.24 M(-15.2%) |
| Mar 2023 | - | -$15.14 M(-21.0%) | -$74.58 M(-9.8%) |
| Dec 2022 | -$82.69 M | -$19.18 M(-3.6%) | -$82.69 M(+1.0%) |
| Sept 2022 | - | -$19.90 M(-2.3%) | -$81.90 M(+14.9%) |
| June 2022 | - | -$20.36 M(-12.4%) | -$71.29 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$23.25 M(+26.5%) | -$67.33 M(+16.7%) |
| Dec 2021 | -$57.68 M(+49.3%) | -$18.38 M(+97.8%) | -$57.68 M(+10.5%) |
| Sept 2021 | - | -$9.29 M(-43.3%) | -$52.22 M(-1.1%) |
| June 2021 | - | -$16.40 M(+20.5%) | -$52.80 M(+18.5%) |
| Mar 2021 | - | -$13.61 M(+5.3%) | -$44.55 M(+15.3%) |
| Dec 2020 | -$38.65 M(+87.1%) | -$12.92 M(+30.8%) | -$38.65 M(+50.2%) |
| Sept 2020 | - | -$9.88 M(+21.2%) | -$25.73 M(+62.3%) |
| June 2020 | - | -$8.15 M(+5.8%) | -$15.85 M(+105.8%) |
| Mar 2020 | - | -$7.70 M | -$7.70 M |
| Dec 2019 | -$20.66 M | - | - |
FAQ
- What is Finch Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Finch Therapeutics?
- What is Finch Therapeutics annual EBITDA year-on-year change?
- What is Finch Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Finch Therapeutics?
- What is Finch Therapeutics quarterly EBITDA year-on-year change?
- What is Finch Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Finch Therapeutics?
- What is Finch Therapeutics TTM EBITDA year-on-year change?
What is Finch Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of FNCH is -$32.48 M
What is the all time high annual EBITDA for Finch Therapeutics?
Finch Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$20.66 M
What is Finch Therapeutics annual EBITDA year-on-year change?
Over the past year, FNCH annual earnings before interest, taxes, depreciation & amortization has changed by +$50.20 M (+60.72%)
What is Finch Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of FNCH is -$6.07 M
What is the all time high quarterly EBITDA for Finch Therapeutics?
Finch Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$3.68 M
What is Finch Therapeutics quarterly EBITDA year-on-year change?
Over the past year, FNCH quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.38 M (-64.68%)
What is Finch Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of FNCH is -$19.51 M
What is the all time high TTM EBITDA for Finch Therapeutics?
Finch Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$7.70 M
What is Finch Therapeutics TTM EBITDA year-on-year change?
Over the past year, FNCH TTM earnings before interest, taxes, depreciation & amortization has changed by +$27.51 M (+58.52%)